P. Masci

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

E. Borden, J. Cowens, R. Ganapathi, 2005, Molecular Cancer Therapeutics.

Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival

J. Maciejewski, L. Rybicki, M. Kalaycio, 2005, Bone Marrow Transplantation.

Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon‐α1b: A Second Member of the Interferon‐α Family

T. Olencki, B. Williams, E. Borden, 2007 .

Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.

T. Olencki, B. Williams, E. Borden, 2007, Clinical pharmacology and therapeutics.

New and modified interferon alfas: Preclinical and clinical data

E. Borden, R. Bukowski, P. Patten, 2003, Current oncology reports.